CARBONYL HETEROCYCLIC COMPOUND AND APPLICATION THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240101552A1
SERIAL NO

18026862

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is the carbonyl heterocyclic compound shown in formula (I) or a pharmaceutically acceptable salt thereof, capable of being used as a compound having a targeted lanthionine synthetase C-like protein 2 pathway and being used for the treatment of various conditions, including infectious diseases, autoimmune diseases, diabetes, and chronic inflammatory diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SHANGHAI PHARMACEUTICALS HOLDING CO LTDSHANGHAI 201203

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
HAO, Lijun Shanghai, CN 8 3
KE, Ying Shanghai, CN 11 0
LOU, Jiangsong Shanghai, CN 3 0
XIA, Guangxin Shanghai, CN 24 45
XIANG, Zhijun Shanghai, CN 3 1
ZHANG, Chaoxin Shanghai, CN 2 0
ZHAO, Menghao Shanghai, CN 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation